Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Autism Dev Disord. 2017 Jun;47(6):1673–1681. doi: 10.1007/s10803-017-3084-6

Table 5.

Behavioral-medication only sample characteristics and relationship with GI symptoms

Total N No QPGS GI diagnosis (n = 19) Functional Constipation (n = 21) Non-Retentive Fecal Incontinence (n = 3) Other Rome-III diagnoses (n = 3) P value
Sex 46 0.019
 Male (%) 100.0% (19) 90.5% (19) 100.0% (3) 33.3% (1)
 Female (%) 0.0% (0) 9.5% (2) 0.0% (0) 66.7% (2)
Age: Mean (SD) 46 12.9(3.1) 12.1(3.3) 9.7(3.1) 11.0(4.6) 0.349
Race 46 0.834
 Caucasian (%) 84.2% (16) 90.5% (19) 100.0% (3) 100.0% (3)
 Other race (%) 15.8% (3) 9.5% (2) 0.0% (0) 0.0% (0)
Ethnicity 46 0.737
 Non-Hispanic/Latino (%) 89.5% (17) 95.2% (20) 100.0% (3) 100.0% (3)
 Hispanic/Latino (%) 10.5% (2) 4.8% (1) 0.0% (0) 0.0% (0)
Household income 39 0.190
 Less than 50k (%) 20.0% (3) 47.4% (9) 0.0% (0) 0.0% (0)
 50k or greater (%) 80.0% (12) 52.6% (10) 100.0% (2) 100.0% (3)
ADOS severity score: Mean (SD) 40 8.3(1.8) 7.9(2.1) 8.0(1.7) 9.0(1.7) 0.738
Verbal Status 46 0.055
 Verbal 100.0% (19) 90.5% (19) 66.7% (2) 66.7% (2)
 Nonverbal 0.0% (0) 9.5% (2) 33.3% (1) 33.3% (1)
FSIQ: Mean (SD) 41 88.5(20.3) 78.4(22.0) 58.5(13.4) 91.3(36.7) 0.178